Perspective: The case against radioiodine remnant ablation in patients with well-differentiated thyroid carcinoma

Ian D. Hay, I. Ross McDougall, James C. Sisson

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

We take issue with the stance that postoperative radioiodine remnant ablation should be applied ubiquitously as adjuvant therapy in patients with well-differentiated thyroid carcinoma. In this article, we state the reasons that we believe a compelling case can be made against ablation in most patients.

Original languageEnglish (US)
Pages (from-to)1395-1397
Number of pages3
JournalJournal of Nuclear Medicine
Volume49
Issue number8
DOIs
StatePublished - Aug 1 2008

Keywords

  • Ablation
  • Endocrinology
  • Oncology
  • Radioiodine
  • Radionuclide therapy
  • Thyroid carcinoma

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'Perspective: The case against radioiodine remnant ablation in patients with well-differentiated thyroid carcinoma'. Together they form a unique fingerprint.

  • Cite this